We are live on ! Find out more
PBYI icon

Puma Biotechnology
PBYI

89 hedge funds and large institutions have $115M invested in Puma Biotechnology in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

308% more call options, than puts

Call options by funds: $870K | Put options by funds: $213K

76% more capital invested

Capital invested by funds: $65.5M → $115M (+$49.8M)

40% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 15

7% more funds holding

Funds holding: 83 → 89 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.45% less ownership

Funds ownership: 60.7% → 60.25% (-0.45%)

12% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 26

Holders
89
Holders Change
+6
Holders Change %
+7.23%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
23
Reduced
26
Closed
15
Calls
$870K
Puts
$213K
Net Calls
+$657K
Net Calls Change
-$278K

Top Buyers

1
HIM
Hillsdale Investment Management
Ontario, Canada
+$2.3M
2
Marshall Wace
Marshall Wace
United Kingdom
+$1.11M
3
EI
EAM Investors
California
+$941K
4
Two Sigma Investments
Two Sigma Investments
New York
+$691K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$605K

Top Sellers

1
AC
Armistice Capital
New York
-$2.42M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.4M
3
AA
AlphaCentric Advisors
Puerto Rico
-$1.26M
4
BlackRock
BlackRock
New York
-$1.13M
5
Millennium Management
Millennium Management
New York
-$399K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
101
Royal Bank of Canada
Ontario, Canada
– +$345 +100 New
1 2 3 4
5